Mersana Therapeutics buy Truist Financial Co.
Start price
29.02.24
/
50%
€5.00
Target price
28.02.25
€8.30
Performance (%)
-37.26%
Price
02.05.24
€3.14
Summary
This prediction is currently active. The BUY prediction by Truist_Financial_Co_ for Mersana Therapeutics is performing very badly with a performance of -37.26%. This prediction currently runs until 28.02.25. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Mersana Therapeutics | 17.888% | 17.888% |
iShares Core DAX® | 0.000% | -2.064% |
iShares Nasdaq 100 | 0.626% | -2.884% |
iShares Nikkei 225® | 1.568% | -5.892% |
iShares S&P 500 | 0.334% | -2.281% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Mersana Therapeutics diskutieren
Mersana Therapeutics, Inc. (NASDAQ: MRSN) was upgraded by analysts at Truist Financial Co. from a "hold" rating to a "buy" rating. They now have a $9.00 price target on the stock.
Ratings data for MRSN provided by MarketBeat